Ciantraniliprol: regulación, genéricos y la capacidad de permanencia de una diamida
12 de marzo de 2026 As regulators continue tightening the screws on older insecticide chemistries, crop protection companies are reassessing which molecules will hold their ground in an increasingly complex regulatory and market landscape. One active ingredient drawing attention is cyantraniliprole, a diamide insecticide navigating a mix of regulatory stability, growing generic competition, and steady market demand.
To unpack the molecule’s outlook, AgriBusiness Global habló con Derek Oliphant, Senior Analyst at AgbioInvestor, about how cyantraniliprole fits into the shifting crop protection market.
Regulatory Pressure — and Opportunity
Regulatory scrutiny has reshaped the crop protection sector over the past decade, particularly for older chemistries such as carbamates and organophosphates. Diamides, however, have largely escaped the same level of pressure.
That dynamic could actually work in cyantraniliprole’s favor.
“For diamides in general, this class hasn’t faced the same regulatory pressures as older insecticides,” Oliphant says. “In my view, cyantraniliprole could benefit from regulatory action against alternatives that have already been, or will be, regulated out of certain markets.”
The European Union offers a clear example. With the insecticide spirotetramat no longer approved, cyantraniliprole may step in as a replacement in certain crop systems.
- Relacionados: Cyantraniliprole Under the Environmental Microscope
“With spirotetramat no longer approved in the EU, cyantraniliprole could be a good fit in several fruit and vegetable crops,” Oliphant explains.
Another case comes from oilseed rape production in Europe. For years, phosmet played a key role in controlling flea beetles, particularly where pyrethroid resistance had become widespread. When the active ingredient lost approval in 2022, regulators and industry groups launched initiatives such as the Phosmet Exit Plan to identify alternatives.
Biological options — including azadirachtin, kaolin, and nettle extract — were evaluated but ultimately showed limited effectiveness.
“In that context, cyantraniliprole has received exemptions for flea beetle control in countries including France and Germany,” Oliphant says. “Where it’s available, it represents a viable chemical alternative.”
Generics on the Horizon
While regulatory risks appear relatively low, the bigger shift for cyantraniliprole may come from market forces. As the molecule approaches patent expiry, new manufacturing capacity — particularly in China — is expected to introduce stronger generic competition.
“In the EU, which is widely recognized as the strictest regulatory environment, cyantraniliprole received approval despite some unresolved data gaps,” Oliphant notes. “With no immediate concerns threatening its approval, the risk of non-renewal is considered low.”
In the United States, regulatory updates have focused primarily on environmental mitigation measures. The U.S. Environmental Protection Agency has introduced label requirements aimed at reducing potential impacts on federally threatened or endangered species, including drift-reducing spray nozzles, buffer zones near water bodies, and application techniques designed to limit off-target spray.
Those measures, Oliphant says, are unlikely to significantly curb usage.
Instead, the more immediate pressure will likely come from expanding global supply. Several companies are investing in new cyantraniliprole production capacity:
- Huai’an Glory Chemical, a subsidiary of Jiangsu Flag Chemical, has received environmental approval for a production line with a capacity of 500 metric tons per year in Jiangsu Province.
- Inner Mongolia Zhonggao Chemical, part of Zhejiang Zhongshan Chemical Group, is planning a large-scale project that includes a 1,500-ton cyantraniliprole production line within a broader 4,500-ton facility.
- Shandong Yuexing Biotechnology plans to add a 500-ton annual cyantraniliprole line as part of a wider 4,500-ton production project.
- Jiangxi Wisdom Pharmaceutical is pursuing an expansion that includes a 1,000-ton annual production line.
As these projects come online, Oliphant expects increased price competition across global markets.
A Transitional Chemistry — or a Long-Term Player?
Despite looming generic pressure, cyantraniliprole appears far from a fading molecule. Oliphant expects it to remain a commercially relevant active ingredient thanks to its versatility and broad-spectrum control.
“I expect cyantraniliprole to continue holding a strong position,” he says.
The molecule targets both chewing and sucking pests and can be applied through multiple delivery systems, including seed treatments and foliar sprays. That flexibility allows it to fit into a wide range of cropping systems.
Market data reflects that continued demand. Global sales of cyantraniliprole — measured at the ex-manufacturer level in crop protection markets — rose 6% in 2024 to approximately $421 million.
Over the past five years, growth has been particularly strong. Between 2019 and 2024, sales expanded at an average annual rate of 13%.
Looking ahead, growth is expected to slow but remain steady. Oliphant forecasts average annual growth of about 3.4% between 2024 and 2029, slightly ahead of the broader insecticides market.
Expansion into new markets and its role as a replacement for de-registered chemistries are expected to support demand. Those gains, however, will likely be tempered by price declines as generic competition intensifies.
In other words, cyantraniliprole may not be the industry’s newest molecule — but it’s also far from obsolete. Instead, it appears positioned as a durable tool in integrated pest management programs even as the crop protection industry pushes toward newer biological and synthetic solutions.
¡Obtenga el boletín hoy!
